Department of Internal Medicine I, Kawasaki Medical School, Kita-ku, Okayama, Japan.
Respirology. 2012 Oct;17(7):1073-9. doi: 10.1111/j.1440-1843.2012.02188.x.
The Japanese Respiratory Society (JRS) scoring system is a useful tool for the early and simple presumptive diagnosis of atypical pneumonia (Mycoplasma pneumoniae and Chlamydia pneumoniae pneumonia). However, it has been suggested that it is difficult to diagnose atypical pneumonia in the elderly using this system. In the present study, we evaluated the accuracy and usefulness of the JRS scoring system for diagnosing atypical pneumonia in different age groups.
Cases of M. pneumoniae (n = 262), C. pneumoniae (n = 98) and common bacterial pneumonia (n = 364) were analysed.
For both atypical pneumonias, the frequency of comorbid illnesses and being in a higher risk category were significantly greater in elderly (age ≥60 years) than in non-elderly patients (age <60 years). One or more additional aetiological factors were more frequently present in elderly than in non-elderly patients. The diagnostic sensitivity and specificity for atypical pneumonia were 39% and 88%, respectively, in the elderly group, and 86% and 88%, respectively, in the non-elderly group. When the patients were stratified into 10-year age groups, the diagnostic sensitivity was highest in the 18- to 29-year age group and decreased from the youngest to the oldest age group.
These results indicate that it is difficult to distinguish between atypical pneumonia and bacterial pneumonia in the elderly using the JRS scoring system. When treating patients aged ≥60 years, physicians should use fluoroquinolones or β-lactam antibiotics + macrolides as empirical first-choice drugs so as to always provide antibiotic protection against potential atypical pathogens.
日本呼吸学会(JRS)评分系统是一种用于早期、简单地推测诊断非典型性肺炎(肺炎支原体和肺炎衣原体肺炎)的有用工具。然而,有人认为该系统难以诊断老年人的非典型性肺炎。本研究评估了 JRS 评分系统在不同年龄组诊断非典型性肺炎的准确性和实用性。
分析了肺炎支原体(n = 262)、肺炎衣原体(n = 98)和常见细菌性肺炎(n = 364)的病例。
对于这两种非典型性肺炎,老年(年龄≥60 岁)患者比非老年患者(年龄<60 岁)合并症和处于较高风险类别的频率明显更高。老年患者比非老年患者更常存在一个或多个其他病因因素。老年组非典型性肺炎的诊断敏感性和特异性分别为 39%和 88%,非老年组分别为 86%和 88%。当患者按 10 岁年龄组分层时,诊断敏感性在 18-29 岁年龄组最高,从最年轻到最年长年龄组逐渐降低。
这些结果表明,JRS 评分系统难以区分老年人的非典型性肺炎和细菌性肺炎。治疗年龄≥60 岁的患者时,医生应将氟喹诺酮类或β-内酰胺类抗生素+大环内酯类作为经验性首选药物,以始终为潜在的非典型病原体提供抗生素保护。